Why are you reporting this TALK?
Phase 3 BREAKWATER Study: Trial Design & Endpoints
Anthony Kerbagenature.com
to learn moreMarch 14, 2026
10 min
Channels
DiscoveryAllergyCardiologyDermatologyEndocrinologyGastroenterologyHematologyHepatologyInfectious DiseaseNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
Phase 3 BREAKWATER Study: Trial Design & Endpoints